Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Betrixaban
2. Bevyxxa
3. N-(5-chloropyridin-2-yl)-2-(4-(n,n-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide
4. Prt054021
1. 936539-80-9
2. Bevyxxa
3. Betrixaban (maleate)
4. Betrixaban Maleate [who-dd]
5. 28z3021tmu
6. N-(5-chloropyridin-2-yl)-2-(4-(n,n-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide Maleate
7. (z)-but-2-enedioic Acid;n-(5-chloropyridin-2-yl)-2-[[4-(n,n-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxybenzamide
8. Benzamide, N-(5-chloro-2-pyridinyl)-2-((4-((dimethylamino)iminomethyl)benzoyl)amino)-5-methoxy-, (2z)-2-butenedioate (1:1)
9. N-(5-chloro-2-pyridinyl)-2-[[4-[(dimethylamino)iminomethyl]benzoyl]amino]-5-methoxybenzamide (2z)-2-butenedioate (1
10. Betrixabanmaleate
11. Unii-28z3021tmu
12. Betrixaban Maleate [mi]
13. Schembl20587587
14. Hy-10268a
15. S5389
16. Akos037515630
17. Ccg-270080
18. Ac-35182
19. Bs-52375
20. Cs-0022563
21. E84423
22. Betrixaban Maleate Salt; Betrixaban Monomaleate; 936539-80-9; Unii-28z3021tmu; 28z3021tmu
Molecular Weight | 568.0 g/mol |
---|---|
Molecular Formula | C27H26ClN5O7 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 9 |
Exact Mass | 567.1520759 g/mol |
Monoisotopic Mass | 567.1520759 g/mol |
Topological Polar Surface Area | 182 Ų |
Heavy Atom Count | 40 |
Formal Charge | 0 |
Complexity | 787 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Prevention of venous thromboembolism
Factor Xa Inhibitors
Endogenous factors and drugs that inhibit or block the activity of FACTOR XA. (See all compounds classified as Factor Xa Inhibitors.)
B01AF
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Betrixaban manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Betrixaban, including repackagers and relabelers. The FDA regulates Betrixaban manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Betrixaban API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Betrixaban manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Betrixaban supplier is an individual or a company that provides Betrixaban active pharmaceutical ingredient (API) or Betrixaban finished formulations upon request. The Betrixaban suppliers may include Betrixaban API manufacturers, exporters, distributors and traders.
click here to find a list of Betrixaban suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Betrixaban DMF (Drug Master File) is a document detailing the whole manufacturing process of Betrixaban active pharmaceutical ingredient (API) in detail. Different forms of Betrixaban DMFs exist exist since differing nations have different regulations, such as Betrixaban USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Betrixaban DMF submitted to regulatory agencies in the US is known as a USDMF. Betrixaban USDMF includes data on Betrixaban's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Betrixaban USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Betrixaban suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Betrixaban as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Betrixaban API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Betrixaban as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Betrixaban and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Betrixaban NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Betrixaban suppliers with NDC on PharmaCompass.
Betrixaban Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Betrixaban GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Betrixaban GMP manufacturer or Betrixaban GMP API supplier for your needs.
A Betrixaban CoA (Certificate of Analysis) is a formal document that attests to Betrixaban's compliance with Betrixaban specifications and serves as a tool for batch-level quality control.
Betrixaban CoA mostly includes findings from lab analyses of a specific batch. For each Betrixaban CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Betrixaban may be tested according to a variety of international standards, such as European Pharmacopoeia (Betrixaban EP), Betrixaban JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Betrixaban USP).
LOOKING FOR A SUPPLIER?